Learn More
Invitrogen™ SARS Coronavirus Nucleocapsid Polyclonal Antibody

Description
The immunogen is 77% ( 10/13) homologous to SARS-COV-2 (COVID-19) Nucleocapsid protein. The cross reactivity is not empirically tested. Suggested positive control: transfected mouse melanoma cell lysate. Immunogen sequence: DLDDFSKQLQ QSM.
Specifications
Specifications
| Antigen | SARS Coronavirus Nucleocapsid |
| Applications | Immunohistochemistry (Paraffin), In Situ Hybridization (ISH), Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene Alias | Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Nucleocapsid; SARS-CoV2; SARS-CoV-2 |
| Host Species | Rabbit |
| Immunogen | Synthetic peptide corresponding to amino acids 399-411 from the N (SARS Nucleocapsid) for the Human SARS coronavirus. |
| Purification Method | Antigen affinity chromatography |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.